Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples